Breaking News Instant updates and real-time market news.

09:45
08/25/20
08/25
09:45
08/25/20
09:45

Consumer Confidence Index to be reported at 10:00

August Consumer Confidence Index will be reported at 10:00 . Current consensus is 93.0

TODAY'S FREE FLY STORIES

Hot Stocks
Houghton Mifflin enters strategic restructuring » 08:09
10/01/20
10/01
08:09
10/01/20
08:09
HMHC

Houghton Mifflin

$1.73 /

+0.045 (+2.68%)

Houghton Mifflin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HMHC Houghton Mifflin
$1.73 /

+0.045 (+2.68%)

HMHC Houghton Mifflin
$1.73 /

+0.045 (+2.68%)

04/07/20 BMO Capital
Houghton Mifflin downgraded to Market Perform from Outperform at BMO Capital
04/03/20 Citi
Houghton Mifflin downgraded to Sell from Buy at Citi
03/10/20 Goldman Sachs
Houghton Mifflin upgraded to Neutral at Goldman Sachs after 43.5% pullback
03/10/20 Goldman Sachs
Houghton Mifflin upgraded to Neutral from Sell at Goldman Sachs
HMHC Houghton Mifflin
$1.73 /

+0.045 (+2.68%)

Recommendations
'Considerable contraction' coming to Penn National shares, Deutsche says » 08:09
10/01/20
10/01
08:09
10/01/20
08:09
PENN

Penn National

$72.71 /

+3.3 (+4.75%)

Penn National Gaming…

Penn National Gaming shares have benefited from the "retail community turning the ticker into an internet meme of sorts," thereby creating momentum in the stock, Deutsche Bank analyst Carlo Santarelli tells investors in a research note. A narrative "that largely abandons fundamental rationale" has been created, says the analyst. Santarelli, who admits he doesn't know when this will end, believes the total addressable market story around sports betting "will start to crack" as more and more data points around per capita spend come to the forefront. Further, the level of sports betting competition will become more evident and questions around margins will begin to appear, predicts Santarelli. The analyst believes the "fundamental and valuation support" under Penn National shares is "lacking," and that "when some or all of these things happen," the stock will see a "considerable contraction." To reflect margin strength in Q3 and favorable core operating revisions, the analyst raised the firm's price target on Penn National Gaming to $31 from $22. Santarelli keeps a Sell rating on Penn with the stock closing Wednesday up $3.29 to $72.70.

ShowHide Related Items >><<
PENN Penn National
$72.71 /

+3.3 (+4.75%)

PENN Penn National
$72.71 /

+3.3 (+4.75%)

07:06 Today Deutsche Bank
Penn National price target raised to $31 from $22 at Deutsche Bank
09/30/20 Craig-Hallum
Penn National price target raised to $90 from $75 at Craig-Hallum
09/30/20 JPMorgan
Penn National price target raised to $83 from $62 at JPMorgan
09/24/20
Fly Intel: Top five analyst downgrades
PENN Penn National
$72.71 /

+3.3 (+4.75%)

  • 25
    Sep
  • 12
    May
PENN Penn National
$72.71 /

+3.3 (+4.75%)

PENN Penn National
$72.71 /

+3.3 (+4.75%)

PENN Penn National
$72.71 /

+3.3 (+4.75%)

Hot Stocks
X4 Pharmaceuticals appoints Allison Lawton to board of directors » 08:09
10/01/20
10/01
08:09
10/01/20
08:09
XFOR

X4 Pharmaceuticals

$6.79 /

+0.22 (+3.35%)

X4 Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XFOR X4 Pharmaceuticals
$6.79 /

+0.22 (+3.35%)

XFOR X4 Pharmaceuticals
$6.79 /

+0.22 (+3.35%)

06/12/20 Roth Capital
X4 Pharmaceuticals data boost confidence in Phase 3 study, says Roth Capital
03/26/20 Citi
X4 Pharmaceuticals an attractive buy trading near cash, says Citi
03/23/20 Citi
Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak
02/13/20 Roth Capital
X4 patent strengthens commercial outlook for mavorixafor, says Roth
XFOR X4 Pharmaceuticals
$6.79 /

+0.22 (+3.35%)

  • 26
    Nov
Hot Stocks
Aditx Therapeutics appoints Jeffery Runge to board of directors » 08:08
10/01/20
10/01
08:08
10/01/20
08:08
ADTX

Aditx Therapeutics

$1.96 /

+0.11 (+5.95%)

Aditx Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADTX Aditx Therapeutics
$1.96 /

+0.11 (+5.95%)

  • 30
    Jun
Recommendations
Terex price target raised to $30 from $25 at Jefferies » 08:07
10/01/20
10/01
08:07
10/01/20
08:07
TEX

Terex

$19.38 /

+0.03 (+0.16%)

Jefferies analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TEX Terex
$19.38 /

+0.03 (+0.16%)

TEX Terex
$19.38 /

+0.03 (+0.16%)

07/27/20 Vertical Research
Terex upgraded to Buy from Hold at Vertical Research
07/14/20 Deutsche Bank
Terex named short-term sell idea at Deutsche Bank
07/01/20 Deutsche Bank
Terex resumed with a Hold at Deutsche Bank
04/24/20
Fly Intel: Top five analyst downgrades
TEX Terex
$19.38 /

+0.03 (+0.16%)

TEX Terex
$19.38 /

+0.03 (+0.16%)

Hot Stocks
Icahn Enterprises enters into agreement with Brett Icahn, adopts succession plan » 08:07
10/01/20
10/01
08:07
10/01/20
08:07
IEP

Icahn Enterprises

$49.00 /

-0.12 (-0.24%)

Icahn Enterprises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IEP Icahn Enterprises
$49.00 /

-0.12 (-0.24%)

IEP Icahn Enterprises
$49.00 /

-0.12 (-0.24%)

IEP Icahn Enterprises
$49.00 /

-0.12 (-0.24%)

Initiation
Humanigen initiated with a Buy at Roth Capital » 08:05
10/01/20
10/01
08:05
10/01/20
08:05
HGEN

Humanigen

$10.56 /

-0.41 (-3.74%)

Roth Capital analyst Tony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HGEN Humanigen
$10.56 /

-0.41 (-3.74%)

  • 18
    Sep
HGEN Humanigen
$10.56 /

-0.41 (-3.74%)

Hot Stocks
TransUnion to acquire Tru Optik, terms not disclosed » 08:05
10/01/20
10/01
08:05
10/01/20
08:05
TRU

TransUnion

$84.16 /

-0.555 (-0.66%)

TransUnion has agreed to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRU TransUnion
$84.16 /

-0.555 (-0.66%)

TRU TransUnion
$84.16 /

-0.555 (-0.66%)

09/10/20 Baird
TransUnion could achieve upside case if trends persist, says Baird
09/02/20 Stephens
Settlement of fight with TransUnion a positive for Fair Isaac, says Stephens
07/22/20
Fly Intel: Top five analyst upgrades
07/22/20 Baird
TransUnion appears stable to improving, Baird upgrades to Outperform
TRU TransUnion
$84.16 /

-0.555 (-0.66%)

Hot Stocks
U.S. Physical Therapy announces its second acquisition of 2020 » 08:05
10/01/20
10/01
08:05
10/01/20
08:05
USPH

U.S. Physical Therapy

$87.15 /

+1.4 (+1.63%)

U.S. Physical Therapy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USPH U.S. Physical Therapy
$87.15 /

+1.4 (+1.63%)

USPH U.S. Physical Therapy
$87.15 /

+1.4 (+1.63%)

08/07/20 Barrington
U.S. Physical Therapy price target raised to $100 from $95 at Barrington
06/08/20 Barrington
U.S. Physical Therapy price target raised to $95 from $84 at Barrington
04/30/20 Sidoti
U.S. Physical Therapy downgraded to Neutral following run-up at Sidoti
04/30/20 Sidoti
U.S. Physical Therapy downgraded to Neutral from Buy at Sidoti
USPH U.S. Physical Therapy
$87.15 /

+1.4 (+1.63%)

Hot Stocks
Ford announces Jim Farley succeeds Jim Hackett as CEO  08:05
10/01/20
10/01
08:05
10/01/20
08:05
F

Ford

$6.66 /

+0.07 (+1.06%)

 
ShowHide Related Items >><<
F Ford
$6.66 /

+0.07 (+1.06%)

F Ford
$6.66 /

+0.07 (+1.06%)

09/18/20 Stifel
Fox Factory upgraded to Buy following pullback at Stifel
09/08/20
Fly Intel: Top five analyst upgrades
09/08/20 Evercore ISI
Evercore ISI giving Ford 'benefit of the doubt,' upgrades to In Line
09/08/20 Evercore ISI
Ford upgraded to In Line from Underperform at Evercore ISI
F Ford
$6.66 /

+0.07 (+1.06%)

F Ford
$6.66 /

+0.07 (+1.06%)

F Ford
$6.66 /

+0.07 (+1.06%)

F Ford
$6.66 /

+0.07 (+1.06%)

Recommendations
Cintas price target raised to $400 from $365 at Jefferies » 08:04
10/01/20
10/01
08:04
10/01/20
08:04
CTAS

Cintas

$333.25 /

+2.88 (+0.87%)

Jefferies analyst Hamzah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTAS Cintas
$333.25 /

+2.88 (+0.87%)

CTAS Cintas
$333.25 /

+2.88 (+0.87%)

07:29 Today Argus
Cintas initiated with a Buy at Argus
09/24/20 Jefferies
Cintas price target raised to $365 from $352 at Jefferies
09/24/20 Stifel
Cintas price target raised to $323 from $288 at Stifel
09/24/20 Baird
Cintas good news increasingly priced in to shares, says Baird
CTAS Cintas
$333.25 /

+2.88 (+0.87%)

CTAS Cintas
$333.25 /

+2.88 (+0.87%)

CTAS Cintas
$333.25 /

+2.88 (+0.87%)

Hot Stocks
Milestone Scientific projects over five-fold sequential increase in sales for Q3 » 08:04
10/01/20
10/01
08:04
10/01/20
08:04
MLSS

Milestone Scientific

$1.39 /

-0.06 (-4.14%)

Milestone Scientific…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MLSS Milestone Scientific
$1.39 /

-0.06 (-4.14%)

MLSS Milestone Scientific
$1.39 /

-0.06 (-4.14%)

09/16/20 Northland
Milestone Scientific initiated with a Market Perform at Northland
  • 26
    Jun
Hot Stocks
Medtronic's Resolute Onyx Drug Eluting Stent one-month therapy approved by FDA » 08:03
10/01/20
10/01
08:03
10/01/20
08:03
MDT

Medtronic

$103.78 /

+1.09 (+1.06%)

Medtronic has received…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDT Medtronic
$103.78 /

+1.09 (+1.06%)

MDT Medtronic
$103.78 /

+1.09 (+1.06%)

09/29/20 Morgan Stanley
Survey indicates Street too conservative on Axonics, says Morgan Stanley
09/29/20 Morgan Stanley
Size, timing of Libre 3 'positive surprises' for Abbott, says Morgan Stanley
09/11/20 Wolfe Research
Medtronic initiated with a Peer Perform at Wolfe Research
08/26/20 Raymond James
Medtronic price target raised to $115 from $107 at Raymond James
MDT Medtronic
$103.78 /

+1.09 (+1.06%)

MDT Medtronic
$103.78 /

+1.09 (+1.06%)

MDT Medtronic
$103.78 /

+1.09 (+1.06%)

MDT Medtronic
$103.78 /

+1.09 (+1.06%)

Hot Stocks
Phreesia acquires co-developed patient care applications by Merck and Geisinger » 08:03
10/01/20
10/01
08:03
10/01/20
08:03
PHR

Phreesia

$32.13 /

+1.22 (+3.95%)

Phreesia is pleased to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHR Phreesia
$32.13 /

+1.22 (+3.95%)

PHR Phreesia
$32.13 /

+1.22 (+3.95%)

09/22/20 DA Davidson
Phreesia initiated with a Buy at DA Davidson
09/22/20 DA Davidson
Phreesia initiated with a Buy at DA Davidson
09/09/20 Piper Sandler
Phreesia price target raised to $35 from $34 at Piper Sandler
07/14/20 Citi
Phreesia initiated with a Neutral at Citi
PHR Phreesia
$32.13 /

+1.22 (+3.95%)

  • 13
    Dec
PHR Phreesia
$32.13 /

+1.22 (+3.95%)

PHR Phreesia
$32.13 /

+1.22 (+3.95%)

Hot Stocks
Melissa announces continuing partnership with Allscripts » 08:03
10/01/20
10/01
08:03
10/01/20
08:03
MDRX

Allscripts

$8.15 /

+0.09 (+1.12%)

Melissa announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDRX Allscripts
$8.15 /

+0.09 (+1.12%)

MDRX Allscripts
$8.15 /

+0.09 (+1.12%)

07/21/20 Goldman Sachs
Allscripts downgraded to Sell from Neutral at Goldman Sachs
06/11/20 Deutsche Bank
Allscripts price target lowered to $9 from $11 at Deutsche Bank
04/22/20 Jefferies
Allscripts downgraded to Hold due to pressure on customers at Jefferies
04/22/20 Jefferies
Allscripts downgraded to Hold from Buy at Jefferies
MDRX Allscripts
$8.15 /

+0.09 (+1.12%)

MDRX Allscripts
$8.15 /

+0.09 (+1.12%)

Hot Stocks
United Health Products submits HemoStyp PMA response to FDA » 08:02
10/01/20
10/01
08:02
10/01/20
08:02
UEEC

United Health Products

$0.00 /

+ (+0.00%)

United Health Products…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UEEC United Health Products
$0.00 /

+ (+0.00%)

11/07/19
United Health Products to hold a corporate update conference call
Hot Stocks
BRP Group to seek new senior secured facilities » 08:02
10/01/20
10/01
08:02
10/01/20
08:02
BRP

BRP Group

$24.91 /

-0.38 (-1.50%)

BRP Group announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRP BRP Group
$24.91 /

-0.38 (-1.50%)

BRP BRP Group
$24.91 /

-0.38 (-1.50%)

08/24/20 Canaccord
BRP Group price target raised to C$70 from C$60 at Canaccord
08/24/20 Raymond James
BRP Group price target raised to $25 from $18 at Raymond James
08/17/20 Jefferies
BRP Group price target raised to $21 from $12 at Jefferies
08/14/20 Keefe Bruyette
BRP Group price target raised to $24 from $19 at Keefe Bruyette
BRP BRP Group
$24.91 /

-0.38 (-1.50%)

  • 25
    Jun
  • 24
    Oct
BRP BRP Group
$24.91 /

-0.38 (-1.50%)

Earnings
Jushi Holdings raises FY21 revenue $205M-$255M from $200M-$250M » 08:00
10/01/20
10/01
08:00
10/01/20
08:00
JUSHF

Jushi Holdings

$0.00 /

+ (+0.00%)

Sees adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

General news
U.S. Challenger reported announced job cuts rose 3.0k to 118.8k in September » 08:00
10/01/20
10/01
08:00
10/01/20
08:00

U.S. Challenger reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Jushi Holdings sees Q4 revenue at high end of $25M-$20M guidance » 07:59
10/01/20
10/01
07:59
10/01/20
07:59
JUSHF

Jushi Holdings

$0.00 /

+ (+0.00%)

Expects to report…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

Earnings
Jushi Holdings sees narrows Q3 revenue view $24M from $22M-$25M  07:58
10/01/20
10/01
07:58
10/01/20
07:58
JUSHF

Jushi Holdings

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

JUSHF Jushi Holdings
$0.00 /

+ (+0.00%)

Recommendations
Azure partnership underscores Datadog's leading position, says Morgan Stanley » 07:58
10/01/20
10/01
07:58
10/01/20
07:58
DDOG

Datadog

$102.55 /

+11.62 (+12.78%)

, MSFT

Microsoft

$210.30 /

+3.13 (+1.51%)

After Datadog (DDOG)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DDOG Datadog
$102.55 /

+11.62 (+12.78%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

DDOG Datadog
$102.55 /

+11.62 (+12.78%)

06:41 Today Mizuho
Datadog price target raised to $116 from $100 at Mizuho
09/25/20 Baird
Baird starts Datadog at Neutral, citing 'premium valuation'
09/24/20 Baird
Datadog initiated with a Neutral at Baird
09/21/20 Summit Insights
Snowflake initiated with a Sell at Summit Insights
MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

06:41 Today Mizuho
Datadog price target raised to $116 from $100 at Mizuho
09/29/20 Summit Insights
Mimecast downgraded to Hold from Buy at Summit Insights
09/29/20 Morgan Stanley
RingCentral price target raised to $300 from $280 at Morgan Stanley
09/24/20 Lynx
Microsoft's Bethesda deal positive for AMD, says Lynx
DDOG Datadog
$102.55 /

+11.62 (+12.78%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

DDOG Datadog
$102.55 /

+11.62 (+12.78%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

DDOG Datadog
$102.55 /

+11.62 (+12.78%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

DDOG Datadog
$102.55 /

+11.62 (+12.78%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

MSFT Microsoft
$210.30 /

+3.13 (+1.51%)

Hot Stocks
Auxly Cannabis reduces workforce to accelerate path to profitability » 07:57
10/01/20
10/01
07:57
10/01/20
07:57
CBWTF

Auxly Cannabis

$0.00 /

+ (+0.00%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

07/16/20 Desjardins
Auxly Cannabis initiated with a Buy at Desjardins
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

Hot Stocks
Auxly Cannabis appoints Michael Lickver as president, Genevieve Young as chair » 07:55
10/01/20
10/01
07:55
10/01/20
07:55
CBWTF

Auxly Cannabis

$0.00 /

+ (+0.00%)

Auxly Cannabis Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

07/16/20 Desjardins
Auxly Cannabis initiated with a Buy at Desjardins
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

Recommendations
Biogen panel meeting can be 'perception catalyst' for Lilly, says Morgan Stanley » 07:54
10/01/20
10/01
07:54
10/01/20
07:54
LLY

Eli Lilly

$148.09 /

+1.83 (+1.25%)

, BIIB

Biogen

$283.44 /

+1.11 (+0.39%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

09/30/20 H.C. Wainwright
Competitor data give Vir Biotechnology 'an opening,' says H.C. Wainwright
09/29/20 Berenberg
Eli Lilly initiated with a Hold at Berenberg
09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
BIIB Biogen
$283.44 /

+1.11 (+0.39%)

09/29/20 Morgan Stanley
Aducanumab AdComm could drive Biogen up or down 20%-30%, says Morgan Stanley
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/18/20 RBC Capital
Biogen price target lowered to $277 from $284 at RBC Capital
09/17/20 Morgan Stanley
Court ruling eliminates hurdle for Tecfidera generics, says Morgan Stanley
LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

LLY Eli Lilly
$148.09 /

+1.83 (+1.25%)

BIIB Biogen
$283.44 /

+1.11 (+0.39%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.